Cofoe Medical Technology Co.,Ltd. (SHE:301087)
China
· Delayed Price · Currency is CNY 59.25
+0.20 (0.34%)
At close: Mar 9, 2026
Cofoe Medical Technology Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 12,039 | 7,192 | 7,791 | 7,606 | 12,626 | - | Upgrade
|
| Market Cap Growth | 70.78% | -7.68% | 2.43% | -39.76% | - | - | Upgrade
|
| Enterprise Value | 10,353 | 5,460 | 5,861 | 5,337 | 12,682 | - | Upgrade
|
| Last Close Price | 59.25 | 33.59 | 34.28 | 32.19 | 51.85 | - | Upgrade
|
| PE Ratio | 37.73 | 23.07 | 30.64 | 25.21 | 29.44 | - | Upgrade
|
| PS Ratio | 3.84 | 2.41 | 2.73 | 2.56 | 5.55 | - | Upgrade
|
| PB Ratio | 2.53 | 1.50 | 1.59 | 1.51 | 2.54 | - | Upgrade
|
| P/TBV Ratio | 2.96 | 1.71 | 1.76 | 1.68 | 2.69 | - | Upgrade
|
| P/FCF Ratio | 18.99 | 13.25 | 378.22 | - | - | - | Upgrade
|
| P/OCF Ratio | 14.73 | 10.84 | 19.78 | 76.89 | 52.61 | - | Upgrade
|
| EV/Sales Ratio | 3.31 | 1.83 | 2.05 | 1.79 | 5.57 | - | Upgrade
|
| EV/EBITDA Ratio | 21.31 | 13.28 | 19.94 | 18.26 | 28.20 | - | Upgrade
|
| EV/EBIT Ratio | 33.22 | 17.63 | 27.87 | 21.24 | 30.13 | - | Upgrade
|
| EV/FCF Ratio | 16.33 | 10.06 | 284.55 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.19 | 0.13 | 0.09 | 0.05 | 0.29 | Upgrade
|
| Debt / EBITDA Ratio | 1.67 | 1.92 | 1.85 | 1.32 | 0.48 | 0.60 | Upgrade
|
| Debt / FCF Ratio | 1.28 | 1.66 | 31.11 | - | - | 2.37 | Upgrade
|
| Net Debt / Equity Ratio | -0.36 | -0.36 | -0.36 | -0.44 | -0.66 | -0.27 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.04 | -4.21 | -6.05 | -7.63 | -7.32 | -0.55 | Upgrade
|
| Net Debt / FCF Ratio | -2.72 | -3.19 | -86.41 | 4.12 | 12.05 | -2.19 | Upgrade
|
| Asset Turnover | 0.48 | 0.47 | 0.45 | 0.49 | 0.60 | 1.67 | Upgrade
|
| Inventory Turnover | 2.24 | 2.27 | 2.87 | 3.64 | 2.94 | 3.89 | Upgrade
|
| Quick Ratio | 1.86 | 2.24 | 2.70 | 2.83 | 5.74 | 1.07 | Upgrade
|
| Current Ratio | 2.38 | 2.88 | 3.53 | 3.54 | 6.62 | 1.71 | Upgrade
|
| Return on Equity (ROE) | 6.74% | 6.43% | 5.09% | 6.04% | 14.40% | 53.09% | Upgrade
|
| Return on Assets (ROA) | 2.99% | 3.06% | 2.08% | 2.57% | 6.92% | 20.64% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.48% | 8.39% | 6.28% | 10.14% | 29.58% | 77.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.40% | 6.10% | 4.10% | 4.80% | 8.20% | 44.30% | Upgrade
|
| Earnings Yield | 2.66% | 4.33% | 3.26% | 3.97% | 3.40% | - | Upgrade
|
| FCF Yield | 5.27% | 7.55% | 0.26% | -7.11% | -2.16% | - | Upgrade
|
| Dividend Yield | 3.05% | 5.36% | 3.50% | 3.73% | 2.37% | - | Upgrade
|
| Payout Ratio | 153.51% | 120.12% | 98.28% | 86.05% | 0.63% | 7.72% | Upgrade
|
| Buyback Yield / Dilution | -0.58% | -0.46% | 1.70% | -26.56% | -5.47% | -0.08% | Upgrade
|
| Total Shareholder Return | 2.47% | 4.90% | 5.20% | -22.83% | -3.09% | -0.08% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.